Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:

Apple Inc. (NASDAQ:AAPL) analysts maintained as Market Perform at BMO Capital Markets ahead of earnings, but the firm raised its target price to 184 from 171. Apple has a 52-wk trading range of 147.30 – 194.20 and a consensus target price of 202.08.

Biogen Inc. (NASDAQ:BIIB) was reiterated as Buy and the price target was raised to 396 from 335 at Canaccord Genuity. Biogen had a consensus target price of 367.08.

Caesars Entertainment Corp. (NASDAQ:CZR) was started as Buy and was assigned a 14 price objective at Merrill Lynch, and the consensus target price is 15.83.

ConocoPhillips (NYSE:COP) was reiterated as Outperform and the price target was raised to 85 from 82 at RBC Capital Markets, and the consensus analyst target is $78.23.

Delphi Technologies PLC (NYSE:DLPH) was raised to Outperform from Perform and assigned a 53 price target at Oppenheimer, and  consensus target price at 58.31.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :